Filter
226
Text search:
pharmacological
interventions
Featured
Recommendations
36
New Publications
38
Language
Document type
No document type
135
Guidelines
34
Studies & Reports
22
Manuals
15
Training Material
7
Strategic & Response Plan
6
Fact sheets
5
Situation Updates
1
Resource Platforms
1
Countries / Regions
Global
11
India
8
Kenya
8
Western and Central Europe
8
South Africa
6
Latin America and the Carribbean
6
Eastern Europe
5
Rwanda
4
Nigeria
3
Ethiopia
3
Asia
3
Uganda
2
Zimbabwe
2
Syria
2
Ukraine
2
Russia
2
Guinea
1
Sierra Leone
1
Liberia
1
Senegal
1
Ghana
1
Philippines
1
Nepal
1
South Sudan
1
Jordan
1
Germany
1
Tanzania
1
Cambodia
1
Bangladesh
1
Papua New Guinea
1
Peru
1
Eswatini/ Swaziland
1
Hungary
1
Lesotho
1
Middle East and North Africa
1
South–East Asia Region
1
Africa
1
Poland
1
Uzbekistan
1
Gabon
1
Turkmenistan
1
Authors & Publishers
Publication Years
Category
Countries
44
Clinical Guidelines
35
Public Health
15
Women & Child Health
13
Capacity Building
3
Pharmacy & Technologies
3
Key Resources
2
Toolboxes
Mental Health
92
NCDs
17
COVID-19
9
TB
8
Caregiver
7
Pharmacy
7
HIV
6
AMR
6
Refugee
4
NTDs
3
Disability
2
Conflict
2
Planetary Health
2
Ebola & Marburg
1
Polio
1
Natural Hazards
1
Zika
1
Specific Hazards
1
Global Health Education
1
Social Ethics
1
This document provides information for WHO Member States, particularly low-income and middle-income countries, to strengthen preparedness and response plans with regard to the social and mental health consequences of biological and chemical attacks.
Epilepsies: diagnosis and management
recommended
Clinical guideline | Published: 11 January 2012 | nice.org.uk/guidance/cg137
Cancer
recommended
This volume presents the complex patterns of cancer incidence and death around the world and evidence on effective and cost-effective ways to control cancers. The Disease Control Priorities Volume 3 evaluation of cancer will indicate where cancer treatment is ineffective and wasteful, and offer alte
...
Disease Control Priorities, 3rdEdition: Volume 4.
Mental, neurological, and substance use disorders are common, highly disabling, and associated with significant premature mortality. The impact of these disorders on the social and economic well-beingof individuals, families, and societies is large
...
WHO clinical guidelines.
For the first time, WHO has published guidelines to help (primarily) front-line healthcare providers give high-quality, compassionate, and respectful care to children and adolescents (up to age 18) who have or may have experienced sexual abuse, including sexual assault or r
...
EU Compass for Action on Mental Health and Well-being
A Manual for Medical Officer
Developed under the Government of India – WHO Collaborative Programme 2008-2009
Accessed: 11.03.2019
Other disorders
Chapter H.5.1
2nd edition. These guidelines include several notable changes from the first edition. For cutaneous leishmaniasis, ketoconazole has been removed from the list of treatment options; the number of Leishmania species for which there is strong evidence for the efficacy of miltefosine has increased from
...
Guidelines on the management of chronic pain in children, developing and implementing national and local policies for pain management and protocols in children, implementing national and local regulations for pain management in children, pain management and protocols
Addressing comorbidities and risk factors for tuberculosis (TB) is a crucial component of the World Health Organization (WHO)’s End TB Strategy. This WHO operational handbook on tuberculosis. Module 6: tuberculosis and comorbidities aims to support countries in scaling up people-centred care,
...
Selection and Use of Essential Medicines 2021
recommended
The 23rd meeting of the WHO Expert Committee on Selection and Use of Essential Medicines was coordinated from Geneva, Switzerland, and held virtually from 21 June to 2 July 2021. The Committee considered 88 applications proposing additions, changes and deletions of medicines, medicine classes and fo
...
Mohamed et al. BMC Public Health 2018, 18(Suppl 3):1215
https://doi.org/10.1186/s12889-018-6053-xpre-
